Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.

Kelly AD, Kroeger H, Yamazaki J, Taby R, Neumann F, Yu S, Lee JT, Patel B, Li Y, He R, Liang S, Lu Y, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Jelinek J, Issa JP.

Leukemia. 2017 Oct;31(10):2011-2019. doi: 10.1038/leu.2017.12. Epub 2017 Jan 11.

2.

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP.

J Natl Cancer Inst. 2015 Nov 13;108(2). pii: djv323. doi: 10.1093/jnci/djv323.

3.

TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, Issa JP.

Cancer Res. 2015 Jul 15;75(14):2833-43. doi: 10.1158/0008-5472.CAN-14-0739. Epub 2015 May 13.

4.

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.

Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, Kantarjian HM, Estecio MR, Jelinek J, Godley LA, Issa JP.

Epigenetics. 2012 Feb;7(2):201-7. doi: 10.4161/epi.7.2.19015.

5.

DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory.

Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estécio MR, Issa JP.

Cancer Res. 2012 Mar 1;72(5):1170-81. doi: 10.1158/0008-5472.CAN-11-3248. Epub 2012 Jan 4.

6.

Cancer epigenetics.

Taby R, Issa JP.

CA Cancer J Clin. 2010 Nov-Dec;60(6):376-92. doi: 10.3322/caac.20085. Epub 2010 Oct 19. Review.

7.

La bronchoscopie, procédé d'exploration et de traitement.

IMBERT J, TABY R.

Maroc Med. 1948 Jun;27(277):261. Undetermined Language. No abstract available.

PMID:
18875908

Supplemental Content

Support Center